Finally! Be free from smoking

Archive for the ‘Treatment’ Category

Debi wrote an interesting post today on
Here’s a quick excerpt
The system is known as the Flare, and it involves injecting a special chemical into a target – such as a cancerous tumor – and then using near-infrared light to highlight the target on a monitor.
By visually separating the bad from the good, it is designed to help surgeons remove all of the diseased tissue while leaving behind the healthy tissue.
The system has been described as “cutting by color,” but Frangioni prefers the phrase “seeing is curing” because he thinks cutting is just the start.
“If we can drag a light bulb to the cancer, why not drag a bomb that can kill it?” he said. “But that’s in the future. This decade is the seeing decade. The next decade is for curing.”

Read the rest of this great post here

Debi wrote an interesting post today on
Here’s a quick excerpt
Many of the therapies are still in clinical trials, and research is limited on handling side effects and determining proper dosage. Through their work with patients, nurses can help determine which patients benefit most from which drugs and in what amounts. This data can help control the considerable costs. One of the most popular targeted therapies, Avastin, when used for metastatic breast cancer, can cost $7,700 per month wholesale. Tarceva, when used for lung cancer, can cost $3,375 per month, says a spokesperson for pharmaceutical company Genentech. Nurses may need to work with pharmacies, social workers, and insurance companies to determine how a patient will pay for the treatments.

Read the rest of this great post here

Debi wrote an interesting post today on
Here’s a quick excerpt
One of the world’s leading drug companies is threatening to withdraw some of its new cancer treatments from the process by which they are approved for use in the National Health Service.
Cancer patients in Britain will consequently be denied more effective drugs that are available to sufferers in other countries.
Roche, the Swiss pharmaceutical giant, has already refused to supply economic data on its drug Avastin for treatment of lung and breast cancer to the National Institute for Health and Clinical Excellence (Nice), the authority that evaluates the cost-effectiveness of medicines for the NHS. This means Avastin will not be available on the NHS for those diseases.

Read the rest of this great post here

Debi wrote an interesting post today on
Here’s a quick excerpt
Dr Lee Kim Shang, Consultant Radiation Oncologist from the Radiation Oncology Centre of PCC said that this technology is a new, revolutionary way of treating cancer as the machine “can deliver very accurate radiation into the tumour and at the same time reducing the radiation in the surrounding healthy cells”.
“It looks like a big CT Scanner, instead of doing just scan, it also produces X-rays that are strong enough to treat cancer. It can be used to treat various cancer diseases such as lung cancer, breast cancer, head and neck cancer and spinal cord cancer is just among the list.”

Read the rest of this great post here

Debi wrote an interesting post today on
Here’s a quick excerpt
The cuttings are sold to drug companies, which extract from them a key ingredient of docetaxel, a chemotherapy drug used for breast, ovarian and lung cancer.

Read the rest of this great post here

Debi wrote an interesting post today on
Here’s a quick excerpt
Cancer is the fastest-growing section of the drugs market but developing new treatments is only half the battle. Persuading payers to use them, particularly in Europe, is another matter.
Recent multi-billion dollar bids for Genentech and ImClone by Roche and Bristol-Myers Squibb highlight Big Pharma’s desire to secure revenues from modern cancer blockbusters like Avastin and Erbitux.
Yet use of both these medicines remains controversial in key European markets, where state-backed healthcare systems are struggling with the escalating cost of cancer treatments.

Read the rest of this great post here

Debi wrote an interesting post today on
Here’s a quick excerpt
On Monday, the US Food and Drug Administration (FDA) posted on its website, a copy of a letter from Genentech Inc, the makers of cancer drug Avastin, to healthcare providers that warns them about a type anemia seen in clinical trial patients treated with Avastin in combination with Pfizer Inc’s Sutent (sunitinib malate).

Read the rest of this great post here

nospam@example.com (Clear the Smoke) wrote an interesting post today on
Here’s a quick excerpt
A new gene screening test may help determine which lung cancer patients have the potential to live longer.In 2008, roughly 215,000 people in the United States will be diagnosed with lung cancer, which contributes to more deaths than any other cancer. Now a genetic test could help doctors determine which non-small-cell lung cancer patients can profit from taking a second cancer drug in addition to chemotherapy.

Read the rest of this great post here

Debi wrote an interesting post today on
Here’s a quick excerpt
AngioDynamics, Inc. has declared another victory in the war on cancer.The company, which employs approximately 540 people at its Airport Industrial Park location, announced Monday the results of a study that showed how the firm’s “Starburst XL” radio-frequency device can be used to destroy lung cancer tumors.

Read the rest of this great post here

nospam@example.com (Clear the Smoke) wrote an interesting post today on
Here’s a quick excerpt
Chemotherapy patients have not lost access to care despite federal legislation that has reduced reimbursements to their doctors in recent years, a new report finds.Critics feared the passing of the Medicare Modernization Act of 2003 would make treatment more difficult, but investigators from the Duke Clinical Research Institute (DCRI) found little difference in the distance chemo patients traveled to be treated and the time between diagnosis and start of treatment.

Read the rest of this great post here